Experimental Alzheimer’s drug slows cognitive decline in trial

MELBOURNE: An experimental Alzheimer’s drug slowed cognitive and functional decline by 27 percent in a

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In